Skip to main content

Freeline Therapeutics Holdings PLC (FRLN)

NASDAQ: FRLN · Delayed Price · USD
3.02
-0.10 (-3.21%)
After-hours:Oct 25, 2021 7:42 PM EDT
3.12
-0.03 (-0.95%)
At close: Oct 25, 4:00 PM

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year202020192018
Selling, General & Admin
26.316.66.79
Research & Development
76.1547.0434.19
Operating Expenses
102.4563.6440.98
Operating Income
-102.45-63.64-40.98
Other Expense / Income
-6.26-9.88-7.73
Pretax Income
-96.19-53.77-33.26
Income Tax
0.130.140.03
Net Income
-96.32-53.91-33.28
Net Income Common
-96.32-53.91-33.28
Shares Outstanding (Basic)
1465
Shares Outstanding (Diluted)
1465
Shares Change
122.96%37.35%-
EPS (Basic)
-6.81-8.49-7.20
EPS (Diluted)
-6.81-8.49-7.20
Free Cash Flow Per Share
-6.88-8.71-6.38
Effective Tax Rate
-0.13%-0.26%-0.08%
EBITDA
-94.28-52.23-32.29
EBIT
-96.19-53.77-33.26
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).